Phibro Animal Health Corporation logo

Phibro Animal Health Corporation (PAHC)

Market Closed
16 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS)
$
38. 82
+0.84
+2.2117%
$
1.55B Market Cap
35.95 P/E Ratio
0.48% Div Yield
187,000 Volume
1.1 Eps
$ 37.98
Previous Close
Add Transaction
Day Range
37.24 38.94
Year Range
28.25 60.08
Want to track PAHC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
PAHC or BSX: Which Is the Better Value Stock Right Now?

PAHC or BSX: Which Is the Better Value Stock Right Now?

Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks | 11 months ago
Why Phibro Animal Health (PAHC) is a Top Growth Stock for the Long-Term

Why Phibro Animal Health (PAHC) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 11 months ago
Phibro Animal Health Corporation (PAHC) Q1 2026 Earnings Call Transcript

Phibro Animal Health Corporation (PAHC) Q1 2026 Earnings Call Transcript

Phibro Animal Health Corporation ( PAHC ) Q1 2026 Earnings Call November 6, 2025 9:00 AM EST Company Participants Glenn David - Chief Financial Officer Jack Bendheim - Chairman, President & CEO Larry Miller - Chief Operating Officer Daniel Bendheim - Executive VP of Corporate Strategy & Director Conference Call Participants Erin Wilson Wright - Morgan Stanley, Research Division Ekaterina Knyazkova - JPMorgan Chase & Co, Research Division Navann Ty Dietschi - BNP Paribas, Research Division Presentation Operator Hello, and thank you for standing by. Welcome to the Phibro Animal Health Corporation First Quarter 2026 Webcast and Conference Call.

Seekingalpha | 11 months ago
Is Phibro (PAHC) a Solid Growth Stock? 3 Reasons to Think "Yes"

Is Phibro (PAHC) a Solid Growth Stock? 3 Reasons to Think "Yes"

Phibro (PAHC) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks | 11 months ago
PAHC vs. BSX: Which Stock Is the Better Value Option?

PAHC vs. BSX: Which Stock Is the Better Value Option?

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks | 11 months ago
Phibro Animal Health Corporation (PAHC) Hits Fresh High: Is There Still Room to Run?

Phibro Animal Health Corporation (PAHC) Hits Fresh High: Is There Still Room to Run?

Phibro (PAHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks | 0 year ago
PAHC or BSX: Which Is the Better Value Stock Right Now?

PAHC or BSX: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks | 1 year ago
Phibro Animal Health Corporation (PAHC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Phibro Animal Health Corporation (PAHC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Phibro Animal Health Corporation (NASDAQ:PAHC ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 12:20 PM EDT Company Participants Glenn David - Chief Financial Officer Conference Call Participants Erin Wilson Wright - Morgan Stanley, Research Division Presentation Erin Wilson Wright Equity Analyst Hi. Good afternoon, everyone.

Seekingalpha | 1 year ago
Phibro Animal Health Corporation (PAHC) Q4 2025 Earnings Conference Call Transcript

Phibro Animal Health Corporation (PAHC) Q4 2025 Earnings Conference Call Transcript

Phibro Animal Health Corporation (NASDAQ:PAHC ) Q4 2025 Earnings Conference August 28, 2025 9:00 AM ET Company Participants Daniel M. Bendheim - Executive VP of Corporate Strategy & Director Glenn C.

Seekingalpha | 1 year ago
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock

Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 1 year ago
PAHC vs. BSX: Which Stock Is the Better Value Option?

PAHC vs. BSX: Which Stock Is the Better Value Option?

Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks is more attractive to value investors?

Zacks | 1 year ago
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?

Should Value Investors Buy Phibro Animal Health (PAHC) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 1 year ago
Loading...
Load More